Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer
Status:
Withdrawn
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether temozolomide followed by nivolumab is an
effective treatment for MMR-proficient colorectal cancer, while causing few or mild side
effects.